DK1459739T3 - Ikke-hydroskopiske farmaceutiske sammensætninger indeholdende ikke-hydratiserede quinolin-carboxylsyrer - Google Patents
Ikke-hydroskopiske farmaceutiske sammensætninger indeholdende ikke-hydratiserede quinolin-carboxylsyrerInfo
- Publication number
- DK1459739T3 DK1459739T3 DK03006160T DK03006160T DK1459739T3 DK 1459739 T3 DK1459739 T3 DK 1459739T3 DK 03006160 T DK03006160 T DK 03006160T DK 03006160 T DK03006160 T DK 03006160T DK 1459739 T3 DK1459739 T3 DK 1459739T3
- Authority
- DK
- Denmark
- Prior art keywords
- hydroscopic
- quinoline carboxylic
- pharmaceutical compositions
- carboxylic acids
- compositions containing
- Prior art date
Links
- LOAUVZALPPNFOQ-UHFFFAOYSA-N quinaldic acid Chemical class C1=CC=CC2=NC(C(=O)O)=CC=C21 LOAUVZALPPNFOQ-UHFFFAOYSA-N 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000006186 oral dosage form Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
- 238000005550 wet granulation Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03006160A EP1459739B1 (en) | 2003-03-19 | 2003-03-19 | Non-hygroscopic pharmaceutical compositions containing non-hydrated quinoline carboxylic acids |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1459739T3 true DK1459739T3 (da) | 2008-05-19 |
Family
ID=32798836
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK03006160T DK1459739T3 (da) | 2003-03-19 | 2003-03-19 | Ikke-hydroskopiske farmaceutiske sammensætninger indeholdende ikke-hydratiserede quinolin-carboxylsyrer |
Country Status (7)
Country | Link |
---|---|
US (1) | US20040224014A1 (da) |
EP (1) | EP1459739B1 (da) |
JP (1) | JP2004339198A (da) |
AT (1) | ATE382338T1 (da) |
DE (1) | DE60318384T2 (da) |
DK (1) | DK1459739T3 (da) |
ES (1) | ES2297067T3 (da) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006110815A1 (en) * | 2005-04-11 | 2006-10-19 | Abbott Laboratories | Pharmaceutical compositions having improved dissolution profiles for poorly soluble drugs |
US8524734B2 (en) | 2005-05-18 | 2013-09-03 | Mpex Pharmaceuticals, Inc. | Aerosolized fluoroquinolones and uses thereof |
CN104173323B (zh) * | 2005-05-18 | 2018-04-03 | 拉普特制药有限公司 | 气溶胶化的氟喹诺酮类药物及其应用 |
EP2101733B1 (en) | 2006-12-13 | 2012-09-26 | F. Hoffmann-La Roche AG | Powder formulation for valganciclovir |
SI2346509T1 (sl) | 2008-10-07 | 2020-08-31 | Horizon Orphan Llc | Inhalacija levofloksacina za zmanjšanje vnetja pljuč |
MX345158B (es) | 2008-10-07 | 2017-01-18 | Raptor Pharmaceuticals Inc | Formulaciones de fluoroquinolona en aerosol para farmacocinetica mejorada. |
CA2773033C (en) | 2009-09-04 | 2016-10-11 | Mpex Pharmaceuticals, Inc. | Use of aerosolized levofloxacin for treating cystic fibrosis |
BR112014012994A2 (pt) * | 2011-11-30 | 2017-06-13 | Toyama Chemical Co Ltd | tablete contendo hidrato de metanossulfonato do ácido 1-ciclopropil-8-(difluorometóxi)-7-[(1r)-1-metil-2,3-diidro-1h-isoindol-5-il]-4-oxo-1, 4-diidroquinolina-3-carboxílico |
JP5700740B1 (ja) | 2013-04-25 | 2015-04-15 | 杏林製薬株式会社 | 固形医薬組成物 |
WO2014174846A1 (ja) | 2013-04-25 | 2014-10-30 | 杏林製薬株式会社 | 固形医薬組成物 |
CA2965473A1 (en) | 2014-10-23 | 2016-04-28 | Kyorin-Pharmaceutical Co., Ltd. | Solid pharmaceutical composition |
CN106310229A (zh) * | 2015-06-30 | 2017-01-11 | 深圳翰宇药业股份有限公司 | 一种马昔瑞林薄膜衣片及其制备方法 |
CN107115312A (zh) * | 2017-05-17 | 2017-09-01 | 湖南新汇制药股份有限公司 | 一种诺氟沙星片及其制备方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4639458A (en) * | 1985-01-22 | 1987-01-27 | Merck & Co., Inc. | Tablet and formulation |
CA2227314A1 (en) * | 1997-01-24 | 1998-07-24 | Hoechst Aktiengesellschaft | Preparation of concealed taste preparations of antibacterially active quinolone derivatives |
PA8466701A1 (es) * | 1998-01-21 | 2000-09-29 | Pfizer Prod Inc | Comprimido de mesilato de trovafloxacino |
US7250176B1 (en) * | 1999-04-13 | 2007-07-31 | Beecham Pharmaceuticals (Pte) Limited | Method of treating a bacterial infection |
IT1319664B1 (it) * | 2000-11-17 | 2003-10-23 | Pharma Biotech Ltd | Addotti di antibatterici chinolonici con polimeri polisaccaridicinaturali. |
-
2003
- 2003-03-19 ES ES03006160T patent/ES2297067T3/es not_active Expired - Lifetime
- 2003-03-19 DK DK03006160T patent/DK1459739T3/da active
- 2003-03-19 EP EP03006160A patent/EP1459739B1/en not_active Expired - Lifetime
- 2003-03-19 DE DE60318384T patent/DE60318384T2/de not_active Expired - Fee Related
- 2003-03-19 AT AT03006160T patent/ATE382338T1/de not_active IP Right Cessation
-
2004
- 2004-03-09 US US10/796,451 patent/US20040224014A1/en not_active Abandoned
- 2004-03-19 JP JP2004079822A patent/JP2004339198A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2004339198A (ja) | 2004-12-02 |
US20040224014A1 (en) | 2004-11-11 |
ES2297067T3 (es) | 2008-05-01 |
DE60318384D1 (de) | 2008-02-14 |
ATE382338T1 (de) | 2008-01-15 |
DE60318384T2 (de) | 2009-02-19 |
EP1459739B1 (en) | 2008-01-02 |
EP1459739A1 (en) | 2004-09-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1459739T3 (da) | Ikke-hydroskopiske farmaceutiske sammensætninger indeholdende ikke-hydratiserede quinolin-carboxylsyrer | |
UA100966C2 (ru) | Фармацевтическая композиция на основе 2-[4-(4-хлорбензоил)фенокси]-2-метилпропионовой кислоты и ее солей | |
DE60131088D1 (de) | Gelierende wässrige pharmazeutische zusammensetzungen | |
MA30554B1 (fr) | Malates et formes polymorphes de l'acide ( 3s,5s)-7-[3-amino-5-methyl-piperidinyl ]-1-cyclopropyl-1,4-dihydro-8- methoxy-4-oxo-3-quinoleine-carboxylique | |
CY2015045I1 (el) | Φαρμακευτικες συνθεσεις ελεγχομενης απελευθερωσης που περιλαμβανουν εστερα φουμαρικου οξεος | |
DE60239425D1 (de) | Kalziumatorvastatin enthaltende arzneiformulierung | |
ATE362314T1 (de) | Herbizidzusammensetzungen umfassend imidazolinonsäure | |
EP2015762A4 (en) | ANTIMICROBIAL COMPOSITIONS CONTAINING HEPAIC ACID ALKALISALES AND ITS USES | |
EP2036565A4 (en) | PREPARATION FOR EXTERNAL APPLICATION TO THE SKIN WITH TRITERPENIC ACID | |
DK1396270T3 (da) | Borsyresalte | |
IL174336A0 (en) | Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient | |
ES2189682B1 (es) | Preparacion bebible que comprende ketoprofeno y su empleo en el tratamiento de procesos que cursan con fiebre, inflamacion y/o dolor, en un colectivo de animales, de forma simultanea. | |
DE602004019049D1 (de) | Stabile feste medizinische zusammensetzung für die orale verabreichung von ramosetron | |
ATE162081T1 (de) | Chinolan-antibiotika und polystyrolsulfonat enthaltende zusammensetzungen | |
DE60025503D1 (de) | Pharmazeutische Zusammensetzungen, die Faropenem Natrium und eine Diamineacetat Verbindung zur Verbesserung der Magen-Darm Trakt Absorption enthalten | |
NL194390B (nl) | Farmaceutische samenstelling die analgetische activiteit bezit met (s)- 2-(6-methoxy-2-naftyl)propionzuur en arginine. | |
BR0311642A (pt) | Formulação de divalproex de sódio de liberação aumentada | |
NO20021898L (no) | Farmasoytisk sammensetning inneholdende ciclesonid for applikasjon til mukosa | |
WO2008020314A3 (en) | Statin stabilizing dosage formulations | |
ATE378335T1 (de) | Chirale fluorochinolizinon arginine salze | |
PE20130180A1 (es) | Soluciones farmaceuticas orales que comprenden telbivudina | |
MA30600B1 (fr) | Formulation medicamenteuse aqueuse d'acide 4-[((4-carboxybutyl)-{2-[(4-phenethyl-benzyl)oxy]-phenethyl}amino)methyl]benzoique. | |
JO2567B1 (en) | Non-water-absorbing pharmaceutical formula containing non-hydrated carboxylic quinoline acids | |
RU2006109966A (ru) | Препарат "янтастим-с" для терапии и профилактики инфекционных заболеваний животных | |
BR0318460A (pt) | sal de arginina de ácido benzoquinolizina-2-carboxìlico tetrahidratado |